Humacyte SG&A Expense (TTM) Analysis

Humacyte Inc (HUMA)

4.91 -0.18 (-3.54%) USD | NASDAQ | Jun 26, 09:57

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
March 31, 2024	20.47M
December 31, 2023	20.39M
September 30, 2023	20.22M
June 30, 2023	20.34M
March 31, 2023	22.44M
December 31, 2022	22.88M

Date	Value
September 30, 2022	22.60M
June 30, 2022	21.81M
March 31, 2022	22.02M
December 31, 2021	21.13M
September 30, 2021	18.17M
June 30, 2021	16.21M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

16.21M

Minimum

Jun 2021

22.88M

Maximum

Dec 2022

20.72M

Average

20.80M

Median

SG&A Expense (TTM) Benchmarks